Clinical Trials and Research

The Center for Research on Women’s Health and Reproductive Medicine is currently conducting the following clinical research studies in reproductive medicine:

AMIGOS Study

The purpose of this research study is to determine which of three medications (gonadotropins, clomiphene or letrozole) may be the best option for fertility treatment when used along with intrauterine insemination. Study participants must be 18 - 40 years old, have nine or more periods per year and have one or more years of infertility. The study covers the cost of treatment. See details (PDF file).

For more information, please contact:

Kathy Turner, RN, NP
Clinical Research Coordinator
kathyt@stanford.edu
(650) 724-6850

Fragile X Premutations Among Women With Infertility

The purpose of this research study is to see how common the Fragile X (FMR1) premutation is in women with a particular infertility-related ovarian condition called “diminished ovarian reserve”. Genes contain instructions that tell our bodies how to develop and function properly. The blood test used in this study will look for a specific genetic abnormality (called “fragile X or FMR1 premutation”) that may indicate an increased chance for developing premature depletion of eggs, early menopause and, infertility. Stanford University and the University of Virginia are collaborating on this study. Enrolled participants will receive a $50 gift card and free genetic testing. Those participants who wish to learn the results of their genetic testing will also receive genetic counseling free of charge.  Please contact Rebecca Briggs for additional information.

Rebecca Briggs
Clinical Research Coordinator
(650) 723-9514

A Study for the Evaluation of Stress Reduction Techniques During In-Vitro Fertilization

The purpose of this research study is to examine the effect of healing touch therapy to reduce stress in women currently undergoing IVF. If you are under the age of 43, undergoing an IVF cycle at the Stanford Fertility and Reproductive Medicine Center, and not currently seeking other energy work (reiki, acupuncture, massage, etc.) then you may be eligible for this study. Women will be randomized to one of three treatment groups: either 3 Healing Touch sessions, or 3 De-sensitization Therapy sessions or no intervention (control group). See details (PDF file). Please contact Allison Carlisle for additional information.

Kathy Turner, ARNP
Clinical Research Coordinator
kathyt@stanford.edu
650-724-6850